2Lakatos L, Pandur T, David G, et al. Extra intestinal manifestation of IBD in Veszprem county(of Hungary) : results of a 25- years follow-up study. Orv Hetil, 2003, 144:1965-1975.
3Mintz R, Feller ER, Bahr RL, et al. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis, 2004, 10:135-139.
5Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: New insights into autoimmune pathogenesis. Dig Dis Sci, 1999, 44:1-13.
6Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol, 2005, 21:408-413.
7Larsen TB, Nielsen JN, Fredholm L, et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease. Pathophysiol Haemost Thromb, 2002, 32:92-96.
8Ibarra-Rodriguez J J, Santiago-Luna E, Velazquez-Ramirez GA, et al. Sensitivity, specificity and predictive values of the level of hemoglobin, hematocrit and platelet count as an activity index in ulcerative colitis. Cir Cir, 2005, 73:355-362.
7Fraquelli M, Losco A, Visentin S, et al. Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases. Arch Intern Med, 2001, 161:2201-2204.
8Florin TH,Graffner H, Nilsson LG, et al. Treatment of joint pain in Crohn's patients with budesonide controlled ileal release. Clin Exp Pharmacol Physiol, 2000, 27:295-298.
9Tromm A,May D, Almus E, et al. Cutaneous manifestations in inflammatory bowel disease. Z Gastroenterol, 2001, 39:137-144.
6Zheng J J, Zhu XS, Huangfu Z, et al. Prevalence and incidence rates of Crohn's disease in China's Mainland: a meta-analysis of 55 years of research [J]. J Dig Dis, 2010, 11(3): 161-166.
